Učitavanje...
Efficacy and safety of bevacizumab for the treatment of glioblastoma
Glioblastoma (GBM) is the most common and devastating primary malignant intracranial tumor in adults. The current first-line treatment for patients with newly diagnosed GBM is surgical resection followed by radiotherapy plus concomitant and adjuvant temozolomide. This treatment protocol may prolong...
Spremljeno u:
| Izdano u: | Exp Ther Med |
|---|---|
| Glavni autori: | , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
D.A. Spandidos
2016
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4733960/ https://ncbi.nlm.nih.gov/pubmed/26893618 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2015.2947 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|